Warkad S. S +4 more
openaire +1 more source
Intensive antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction. [PDF]
Matejka J +12 more
europepmc +1 more source
Ticagrelor Paradox: Systematic Review and Network Meta-Analysis. [PDF]
Watanabe A +14 more
europepmc +1 more source
Effectiveness and Safety of Reduced-Dose Prasugrel in an East Asian Population: PRASFIT-ACS Emulation Using National Health Insurance Claims Data. [PDF]
Huang LW +6 more
europepmc +1 more source
Flow diversion with hydrophilic polymer coating with prasugrel as single antiplatelet therapy in the treatment of acutely ruptured intracranial aneurysms: a multicenter case series, complication and occlusion rates. [PDF]
Khanafer A +18 more
europepmc +1 more source
Efficacy and safety of low-dose prasugrel as dual antiplatelet therapy in patients with ischemic heart disease: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Fujii T +5 more
europepmc +1 more source
Endovascular treatment for subarachnoid hemorrhage during pregnancy followed by minimum approaches for cerebral vasospasm. [PDF]
Maeoka R +3 more
europepmc +1 more source
Antiplatelet therapy and central nervous system hematomas: a cohort study using real-world data from the FAERS and VigiAccess databases. [PDF]
Wang L, Cai H, Zhao S.
europepmc +1 more source

